Extract from: Graziottin A. Gambini D. Perelman M.A. Female sexual dysfunctions: future of medical therapy in: Abdel-Hamid I.A. (Ed), Advances in sexual medicine: drug discovery issues, Research Signpost, Kerala, India, 2009, p. 403-432
Female sexual dysfunction (FSD) is age related, progressive and highly prevalent, affecting up to 20% to 43% of women in the fertile age, and 48% of the older postmenopausal women. Pelvic floor disorders are among the most important and yet neglected medical contributors to womens' sexual dysfunctions. Various degrees of dyspareunia are reported by 15% of coitally active women, and 22.5–33% of postmenopausal women. Vaginismus occurs in 0.5–1% of fertile women. However, mild hyperactivity of the pelvic floor, that could coincide with grade I or II of vaginismus may permit intercourse causing, though, coital pain.
FAIR USE: The content of this paper can be downloaded, printed and read for strictly personal and non-profit use. Any citation for didactic and/or scientific purpose must quote the title of the document, the name of the author(s), the data of the book or journal, and the URL of the site (www.fondazionegraziottin.org).
WARNING: Every therapy must be discussed, tailored, prescribed and monitored by the M.D. personally consulted. Every information presented in this website can not surrogate the personal relationship with the caring physician nor be utilized without specific medical advice.